Open access peer-reviewed chapter

Nanotechnology Based Targeted Drug Delivery: Current Status and Future Prospects for Drug Development

By Sadhna Sharma and Amandeep Singh

Submitted: March 3rd 2011Reviewed: July 20th 2011Published: December 16th 2011

DOI: 10.5772/28902

Downloaded: 5215

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Sadhna Sharma and Amandeep Singh (December 16th 2011). Nanotechnology Based Targeted Drug Delivery: Current Status and Future Prospects for Drug Development, Drug Discovery and Development, Izet M. Kapetanovic, IntechOpen, DOI: 10.5772/28902. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/drug-discovery-and-development-present-and-future/nanotechnology-based-targeted-drug-delivery-current-status-and-future-prospects-for-drug-development" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

5215total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Silver Nanoparticles – Universal Multifunctional Nanoparticles for Bio Sensing, Imaging for Diagnostics and Targeted Drug Delivery for Therapeutic Applications

By Anitha Sironmani and Kiruba Daniel

Related Book

First chapter

In Vitro Biotransformation in Drug Discovery

By Selvan Ravindran, Rutuja Rokade, Jitendra K. Suthar, Pooja Singh, Pooja Deshpande, Rajeshree Khambadkar and Srushti Utekar

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us